SUBSCRIBE
SUBSCRIBE
News   Business

Momenta Pharmaceuticals, Inc. Drops Drug from Deal with Novartis Corporation’ (JOBS) Unit

December 21, 2009 | 
1 min read
Bookmark and Share

Reuters -- Momenta Pharmaceuticals Inc said it agreed with a unit of Switzerland's Novartis to end a collaboration and license agreement on a biosimilar product.
Alliances
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Amgen lays off around 40 employees
July 26, 2026
 · 
70 min read
 · 
BioSpace Editorial Staff
pipeline infographic, industrial background, oil water gas transportation yellow pipes, plumbing system vector illustration
Drug Development
Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped
July 24, 2026
 · 
3 min read
 · 
Gabrielle Masson
A two old parchment scrolls with a quill in a inkwell on a white background
IPO
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
July 24, 2026
 · 
3 min read
 · 
Tristan Manalac
A crowd of abstract multicolored silhouettes of people and conversational bubbles above them, made in the style of a collage. A metaphor for society and cooperation.
Regulatory
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
July 24, 2026
 · 
4 min read
 · 
Annalee Armstrong